WTF-Momente:
Tivicay
Awiqli (noch nie gehört)
Tivicay
Awiqli (noch nie gehört)
April 20, 2025 at 4:58 PM
WTF-Momente:
Tivicay
Awiqli (noch nie gehört)
Tivicay
Awiqli (noch nie gehört)
November 21, 2024 at 9:55 AM
NEW IN DIABETES CARE: The FDA has approved Awiqli® (insulin icodec-abae), the first and only once-weekly basal insulin for adults with type 2 diabetes.
Awiqli® is already approved in the EU and 13 other countries. US approval was granted in March 2026.
https://ow.ly/gm6750Z2ExT
Awiqli® is already approved in the EU and 13 other countries. US approval was granted in March 2026.
https://ow.ly/gm6750Z2ExT
May 23, 2026 at 2:01 PM
NEW IN DIABETES CARE: The FDA has approved Awiqli® (insulin icodec-abae), the first and only once-weekly basal insulin for adults with type 2 diabetes.
Awiqli® is already approved in the EU and 13 other countries. US approval was granted in March 2026.
https://ow.ly/gm6750Z2ExT
Awiqli® is already approved in the EU and 13 other countries. US approval was granted in March 2026.
https://ow.ly/gm6750Z2ExT
Foi aprovada pela Anvisa uma nova insulina que tem como objetivo tornar a rotina de quem convive com diabetes mais fácil.
A insulina icodeca poderá ser aplicada apenas uma vez por semana, ao contrário das opções atuais, que exigem aplicações diárias. Saiba mais!
A insulina icodeca poderá ser aplicada apenas uma vez por semana, ao contrário das opções atuais, que exigem aplicações diárias. Saiba mais!
O que é a insulina semanal, novo medicamento aprovado pela Anvisa - Portal Drauzio Varella
A insulina semanal, que será comercializada com o nome Awiqli, oferece mais praticidade ao paciente com diabetes tipo 1 e 2. Saiba como utilizá-la.
drauziovarella.uol.com.br
April 23, 2025 at 5:53 PM
Foi aprovada pela Anvisa uma nova insulina que tem como objetivo tornar a rotina de quem convive com diabetes mais fácil.
A insulina icodeca poderá ser aplicada apenas uma vez por semana, ao contrário das opções atuais, que exigem aplicações diárias. Saiba mais!
A insulina icodeca poderá ser aplicada apenas uma vez por semana, ao contrário das opções atuais, que exigem aplicações diárias. Saiba mais!
𝘌𝘯𝘵𝘸𝘪𝘤𝘬𝘦𝘭𝘵 𝘸𝘶𝘳𝘥𝘦 𝘈𝘸𝘪𝘲𝘭𝘪 𝘷𝘰𝘯 𝘕𝘰𝘷𝘰 𝘕𝘰𝘳𝘥𝘪𝘴𝘬
Logo
Logo
365 Injektionen werden zu 52: Das erste Wocheninsulin Awiqli ist zugelassen und könnte Millionen Diabetikern den Alltag erleichtern.
Einmal pro Woche statt täglich: neues Insulin für Typ-2
Die FDA hat Awiqli zugelassen, das erste Wocheninsulin für Typ-2-Diabetiker. Statt 365 täglicher Injektionen sind künftig 52 pro Jahr nötig, was die Therapietreue erheblich verbessern soll.
denkstrom.org
April 29, 2026 at 7:20 AM
𝘌𝘯𝘵𝘸𝘪𝘤𝘬𝘦𝘭𝘵 𝘸𝘶𝘳𝘥𝘦 𝘈𝘸𝘪𝘲𝘭𝘪 𝘷𝘰𝘯 𝘕𝘰𝘷𝘰 𝘕𝘰𝘳𝘥𝘪𝘴𝘬
Logo
Logo
FDA clears #$LLY Onswik, a once-weekly basal insulin for adults with type 2 diabetes. It may cut 300+ shots a year and now competes with #$NVO Awiqli. notreload.xyz/xy/lly-onswi...
Lilly Onswik Wins FDA Nod as Weekly Type 2 Insulin
FDA clears Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes. It may cut 300+ shots a year and now competes with Novo’s Awiqli.
notreload.xyz
September 24, 2026 at 1:56 PM
FDA clears #$LLY Onswik, a once-weekly basal insulin for adults with type 2 diabetes. It may cut 300+ shots a year and now competes with #$NVO Awiqli. notreload.xyz/xy/lly-onswi...
A Anvisa (Agência Nacional de Vigilância Sanitária) aprovou a 1ª insulina semanal do mundo para o tratamento de pacientes adultos com diabetes tipo 1 e 2. Trata-se da medicação Awiqli, produzida pela farmacêutica Novo Nordisk. Apesar da aprovação, ainda não há data para lançamento no Brasil...
Anvisa aprova 1ª insulina semanal para tratar diabetes 1 e 2
Ainda não há data para lançamento no Brasil; farmacêutica afirma que programa demonstrou eficácia do medicamento. Leia no Poder360.
www.poder360.com.br
March 8, 2025 at 11:35 PM
A Anvisa (Agência Nacional de Vigilância Sanitária) aprovou a 1ª insulina semanal do mundo para o tratamento de pacientes adultos com diabetes tipo 1 e 2. Trata-se da medicação Awiqli, produzida pela farmacêutica Novo Nordisk. Apesar da aprovação, ainda não há data para lançamento no Brasil...
US FDA approves Novo's insulin injection for type 2 diabetes reut.rs/3NwFmJP
US FDA approves Novo's insulin injection for type 2 diabetes
The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control blood sugar levels in adults living with type 2 diabetes, the company said on Thursday.
reut.rs
March 27, 2026 at 5:15 AM
US FDA approves Novo's insulin injection for type 2 diabetes reut.rs/3NwFmJP
The #FDA has approved #EliLilly's once-weekly #basalinsulin product #Onswik for adults with #type2diabetes, setting up a market tussle with Novo over its recently launched Awiqli.
pharmaphorum.com/news/lillys-...
pharmaphorum.com/news/lillys-...
September 24, 2026 at 1:50 PM
The #FDA has approved #EliLilly's once-weekly #basalinsulin product #Onswik for adults with #type2diabetes, setting up a market tussle with Novo over its recently launched Awiqli.
pharmaphorum.com/news/lillys-...
pharmaphorum.com/news/lillys-...
Novo Nordisk insulin pen price in India: How much will once-weekly Awiqli cost you? Check its variants
Novo Nordisk India launched Awiqli, the first once-weekly basal insulin for diabetes, reducing injections from daily to weekly. In a statement, it said that more than 101 million people in India…
Novo Nordisk India launched Awiqli, the first once-weekly basal insulin for diabetes, reducing injections from daily to weekly. In a statement, it said that more than 101 million people in India…
Novo Nordisk insulin pen price in India: How much will once-weekly Awiqli cost you? Check its variants
Novo Nordisk India launched Awiqli, the first once-weekly basal insulin for diabetes, reducing injections from daily to weekly. In a statement, it said that more than 101 million people in India are living with diabetes, while an additional 136 million have prediabetes.
news-area.com
July 9, 2026 at 11:29 PM
Novo Nordisk insulin pen price in India: How much will once-weekly Awiqli cost you? Check its variants
Novo Nordisk India launched Awiqli, the first once-weekly basal insulin for diabetes, reducing injections from daily to weekly. In a statement, it said that more than 101 million people in India…
Novo Nordisk India launched Awiqli, the first once-weekly basal insulin for diabetes, reducing injections from daily to weekly. In a statement, it said that more than 101 million people in India…
Type 2 diabetics can now reduce insulin shots from 7 times a week to just ONCE. The FDA approved a weekly basal insulin (long-acting) shot, Awiqli. This is based on phase 3 trials with about 2,680 adults. Huge for convenience and compliance!
FDA Approves Novo Nordisk's Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes
The U.S. Food and Drug Administration (FDA) has approved Awiqli (insulin icodec-abae) injection, making it the first and only once-weekly basal insulin for adults with type 2 diabetes. This new treatm
www.medscape.com
April 7, 2026 at 2:02 AM
Type 2 diabetics can now reduce insulin shots from 7 times a week to just ONCE. The FDA approved a weekly basal insulin (long-acting) shot, Awiqli. This is based on phase 3 trials with about 2,680 adults. Huge for convenience and compliance!
NOVO NORDISK: AWIQLI APPROVED IN US AS FIRST ONCE-WEEKLY BASAL INSULIN FOR TYPE 2 DIABETES; US LAUNCH PLANNED FOR H2 2026; NOW APPROVED IN US, EU & 13 OTHER COUNTRIES
March 26, 2026 at 11:39 PM
NOVO NORDISK: AWIQLI APPROVED IN US AS FIRST ONCE-WEEKLY BASAL INSULIN FOR TYPE 2 DIABETES; US LAUNCH PLANNED FOR H2 2026; NOW APPROVED IN US, EU & 13 OTHER COUNTRIES
Awiqliってスペルなんだけど、名前のセンスが小林製薬的だよな。週一回だからアウィクリ（a weekly）って外国にも小林製薬おじさんみたいな人がいるんだろうなと。
January 15, 2025 at 8:36 AM
Awiqliってスペルなんだけど、名前のセンスが小林製薬的だよな。週一回だからアウィクリ（a weekly）って外国にも小林製薬おじさんみたいな人がいるんだろうなと。
Today the FDA approved the first once-weekly insulin.
Insulin icodec, now brand name Awiqli, demonstrated superior a1c reduction to daily insulin glargine with a1c reduction of 1.55% compared to 1.35%, in addition to 6 less injections per week in the ONWARDS phase 3 trial.
Insulin icodec, now brand name Awiqli, demonstrated superior a1c reduction to daily insulin glargine with a1c reduction of 1.55% compared to 1.35%, in addition to 6 less injections per week in the ONWARDS phase 3 trial.
March 27, 2026 at 2:58 AM
Today the FDA approved the first once-weekly insulin.
Insulin icodec, now brand name Awiqli, demonstrated superior a1c reduction to daily insulin glargine with a1c reduction of 1.55% compared to 1.35%, in addition to 6 less injections per week in the ONWARDS phase 3 trial.
Insulin icodec, now brand name Awiqli, demonstrated superior a1c reduction to daily insulin glargine with a1c reduction of 1.55% compared to 1.35%, in addition to 6 less injections per week in the ONWARDS phase 3 trial.
💉 #diabetes
🇺🇸 Eli Lilly's #Onswik won FDA approval on Wednesday, the second once-weekly insulin in the US after 🇩🇰 Novo Nordisk's Awiqli in March.
It lands in the flat half of Novo: insulin has sat near EUR 1.7bn a quarter since 2020, while the incretins beside it went 5.5x.
#$LLY #$NOVO
🇺🇸 Eli Lilly's #Onswik won FDA approval on Wednesday, the second once-weekly insulin in the US after 🇩🇰 Novo Nordisk's Awiqli in March.
It lands in the flat half of Novo: insulin has sat near EUR 1.7bn a quarter since 2020, while the incretins beside it went 5.5x.
#$LLY #$NOVO
September 26, 2026 at 7:00 AM
Le buone notizie non fanno storia.
Io cercavo i prezzi comparati dell'insulina per una discussione sulla sanità in USA ed ho scoperto solo per caso che in Italia è disponibile (e rimborsano) l'insulina settimanale di Novo nordisk (Awiqli).
www.disabili.com/medicina/art...
Io cercavo i prezzi comparati dell'insulina per una discussione sulla sanità in USA ed ho scoperto solo per caso che in Italia è disponibile (e rimborsano) l'insulina settimanale di Novo nordisk (Awiqli).
www.disabili.com/medicina/art...
Diabete. Rimborsabile in Italia la prima insulina settimanale al mondo che sostituisce l’iniezione giornaliera
L’Italia è il primo Paese a consentire il passaggio da 365 iniezioni a 52 all’anno di insulina passata dal SSN
www.disabili.com
June 15, 2026 at 6:36 PM
Le buone notizie non fanno storia.
Io cercavo i prezzi comparati dell'insulina per una discussione sulla sanità in USA ed ho scoperto solo per caso che in Italia è disponibile (e rimborsano) l'insulina settimanale di Novo nordisk (Awiqli).
www.disabili.com/medicina/art...
Io cercavo i prezzi comparati dell'insulina per una discussione sulla sanità in USA ed ho scoperto solo per caso che in Italia è disponibile (e rimborsano) l'insulina settimanale di Novo nordisk (Awiqli).
www.disabili.com/medicina/art...
Wobei Awiqli schon ein sehr Name für das Produkt ist😊
April 20, 2025 at 6:36 PM
Wobei Awiqli schon ein sehr Name für das Produkt ist😊
Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in India on Thursday, aiming to compete with daily-dose options on the market.
Read more by clicking the link in the comment.
Read more by clicking the link in the comment.
July 9, 2026 at 1:32 PM
Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in India on Thursday, aiming to compete with daily-dose options on the market.
Read more by clicking the link in the comment.
Read more by clicking the link in the comment.
Awiqli, the first once-weekly basal insulin for adults with type 2 diabetes, is now available in the US. Lilly’s Onswik may follow later this year.
jcst2d.com/index.php/ne...
#Type2Diabetes #Awiqli #Insulin
jcst2d.com/index.php/ne...
#Type2Diabetes #Awiqli #Insulin
August 12, 2026 at 10:56 PM
Awiqli, the first once-weekly basal insulin for adults with type 2 diabetes, is now available in the US. Lilly’s Onswik may follow later this year.
jcst2d.com/index.php/ne...
#Type2Diabetes #Awiqli #Insulin
jcst2d.com/index.php/ne...
#Type2Diabetes #Awiqli #Insulin
Novo Nordisk launches weekly insulin shot Awiqli in India https://mrf.lu/2NS12
July 9, 2026 at 1:34 PM
Novo Nordisk launches weekly insulin shot Awiqli in India https://mrf.lu/2NS12
Insulina semanal: entenda como funciona o novo remédio para diabetes glo.bo/4hMHFRL
Insulina semanal: entenda como funciona o novo medicamento para tratar diabetes tipo 1 e 2
Insulina basal icodeca, comercializada como Awiqli, foi aprovada pela Anvisa neste mês. Ainda não há uma data prevista para o lançamento no Brasil.
glo.bo
March 18, 2025 at 10:36 PM
Insulina semanal: entenda como funciona o novo remédio para diabetes glo.bo/4hMHFRL
Novo Nordisk Pats Resubmits Awiqli® to the FDA, Aims to be First Weekly Insulin for Adults with Type 2 Diabetes 💉📈
September 29, 2025 at 12:07 PM
Novo Nordisk Pats Resubmits Awiqli® to the FDA, Aims to be First Weekly Insulin for Adults with Type 2 Diabetes 💉📈
365 Injektionen werden zu 52: Das erste Wocheninsulin Awiqli ist zugelassen und könnte Millionen Diabetikern den Alltag erleichtern.
Einmal pro Woche statt täglich: neues Insulin für Typ-2
Die FDA hat Awiqli zugelassen, das erste Wocheninsulin für Typ-2-Diabetiker. Statt 365 täglicher Injektionen sind künftig 52 pro Jahr nötig, was die Therapietreue erheblich verbessern soll.
denkstrom.org
April 28, 2026 at 10:46 PM
365 Injektionen werden zu 52: Das erste Wocheninsulin Awiqli ist zugelassen und könnte Millionen Diabetikern den Alltag erleichtern.
